ACE-031, a synthetic peptide derived from the ActRIIB receptor, has garnered significant attention in scientific investigations for its potential to modulate myostatin, a well-regarded regulator of muscle cell development and homeostasis. Myostatin, a member of the transforming growth factor-beta (TGF-β) superfamily, is hypothesized to play a critical role in regulating muscular tissue growth, acting as a negative regulator by limiting excessive tissue expansion. By potentially binding to and neutralizing myostatin, ACE-031 might offer unique opportunities to investigate physiological processes related to muscular tissue mass, cellular metabolism, and tissue dynamics.

Farmācijas nozares pārstāvji prasībās par izmaiņām jaunajā zāļu uzcenojumu reformā ir nonākuši pretrunās ar sevi, no vienas puses apgalvojot, ka Veselības ministrija (VM) nav ierobežojusi ražotāju cenas medikamentiem, bet no otras puses - aicinot atcelt prasību ražotāju cenas pielīdzināt Lietuvas un Igaunijas līmenim, aģentūrai LETA pauda veselības ministrs Hosams Abu Meri (JV).

Mūsdienu garīgās prakses atbrīvo prātu un atjauno ķermeni.

Syn-AKE Peptide: A Synthetic Innovation with Multifaceted Potential in Biotechnological Research